Polysaccharide colloidal particles as delivery systems for macromolecules

被引:945
作者
Janes, KA [1 ]
Calvo, P [1 ]
Alonso, MJ [1 ]
机构
[1] Univ Santiago de Compostela, Fac Pharm, Dept Pharm & Pharmaceut Technol, Santiago De Compostela 15706, Spain
关键词
chitosan; nanoparticles; nanocapsules; self-assemblies; peptide; protein; DNA; mucosal drug delivery; nasal absorption; gastro-intestinal absorption;
D O I
10.1016/S0169-409X(00)00123-X
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Mucosal delivery of complex molecules such as peptides, proteins, oligonucleotides, and plasmids is one of the most intensively studied subjects. The use of colloidal carriers made of hydrophilic polysaccharides, i.e. chitosan, has arisen as a promising alternative for improving the transport of such macromolecules across biological surfaces. This article reviews the approaches which have aimed to associate macromolecules to chitosan in the form of colloidal structures and analyzes the evidence of their efficacy in improving the transport of the associated molecule through mucosae and epithelia. Chitosan has been shown to form colloidal particles and entrap macromolecules through a number of mechanisms, including ionic crosslinking, desolvation, or ionic complexation, though some of these systems have been realized only in conjunction with DNA molecules. An alternative involving the chemical modification of chitosan has also been useful for the association of macromolecules to self-assemblies and vesicles. To date, the in vivo efficacy of these chitosan-based colloidal carriers has been reported for two different applications: while DNA-chitosan hybrid nanospheres were found to be acceptable transfection carriers, ionically crosslinked chitosan nanoparticles appeared to be efficient vehicles for the transport of peptides across the nasal mucosa. The potential applications and future prospects of these new systems fur mucosal delivery of macromolecules are highlighted at the end of the chapter. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:83 / 97
页数:15
相关论文
共 64 条
[1]
ALONSO MJ, Patent No. 0771566
[2]
ALONSO MJ, Patent No. 0860166
[3]
[Anonymous], P INT S CONTR REL BI
[4]
Arai K., 1968, B TOKAI REGIONAL FIS, V56, P89
[5]
EFFECT OF CHITOSAN ON THE PERMEABILITY OF MONOLAYERS OF INTESTINAL EPITHELIAL-CELLS (CACO-2) [J].
ARTURSSON, P ;
LINDMARK, T ;
DAVIS, SS ;
ILLUM, L .
PHARMACEUTICAL RESEARCH, 1994, 11 (09) :1358-1361
[6]
Behr JP, 1997, CHIMIA, V51, P34
[7]
BERSCH PC, 1995, J MAT SCI MED, V6, P231
[8]
Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for antiinflammatory drugs [J].
Berthold, A ;
Cremer, K ;
Kreuter, J .
JOURNAL OF CONTROLLED RELEASE, 1996, 39 (01) :17-25
[9]
Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres [J].
Blanco, MD ;
Alonso, MJ .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1997, 43 (03) :287-294
[10]
A NOVEL-APPROACH TO THE ORAL DELIVERY OF MICRO-PARTICLES OR NANOPARTICLES [J].
BODMEIER, R ;
CHEN, HG ;
PAERATAKUL, O .
PHARMACEUTICAL RESEARCH, 1989, 6 (05) :413-417